AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 12/06/2024
Closing price: 176.19
Support price level: | N/A |
Resistance price level: | $182.51 |
Relative strength index (14-day RSI) | 72.4 |
Beta | 0.18 |
- ABBV is one of this month's worst performers with a return of -12.1%, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$149.28 | $203.87 | 53.2% |
200 day | 50 day | 20 day | 10 day |
$179.06 | $186.99 | $175.78 | $179.32 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
24.9% | 25.7% | 27.7% | 25.2% |
- 7.5% in the next week.
- 14.3% in the next month.
- 46.7% in the next year.
Company news for AbbVie Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks